-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O2.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Expanding the Donor Pool Clinically Relevant Abstract

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological therapies, Therapies, Transplantation
Monday, December 11, 2023: 4:30 PM-6:00 PM
Ballroom 20AB (San Diego Convention Center)
Moderators:
Mariam T. Nawas, MD, University of Chicago Medical Center and Brian C. Shaffer, MD, National Insitutes of Health
Disclosures:
No relevant conflicts of interest to declare.
This session describes novel methods to improve outcomes of allogeneic hematopoietic cell transplantation from alternative and HLA-mismatched donors.
4:30 PM

Yongxian Hu1*, Mingming Zhang1*, Tingting Yang2*, Ruirui Jing1*, Houli Zhao1*, Rongrong Chen3*, Tianning Gu1*, Pingnan Xiao1*, Ruimin Hong1*, Jingjing Feng1*, Shan Fu1*, Delin Kong1*, Huijun Xu1*, Jiazhen Cui1*, Simao Huang1*, Bin Liang4*, Guoqing Wei5*, Xiaolin Yuan, MD1*, Qu Cui6*, Jiangtao Ren7*, Alex H. Chang8*, Dongrui Wang1* and He Huang5*

1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AE, China
3The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Department of Medical Oncology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
5Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
7Nanjing Bioheng Biotech Co., Ltd, Nanjing, China
8Shanghai YaKe Biotechnology Ltd, Shanghai, China

4:45 PM

Filippo Milano, MD1, Guy Sauvageau, MD/PhD2, Gabrielle Thauvette3*, Nadia M. Bambace, MD4, Lea Bernard, MD5, Imran Ahmad, MD6, Jean Roy, MD7, Laura C Roberts8*, Laurel Thur1*, Jenna B Pedersen8*, Ann Dahlberg, MD8* and Sandra Cohen, MD9

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Institut de recherche en Immunologie et Cancer, Université de Montréal, Montreal, QC, Canada
3Data & Analytics Associate / Quality & Compliance Department, ExCellThera Inc., Montreal, QC, Canada
4Baptist Health South Florida, Miami Cancer Institute, Miami, FL
5Maisonneuve-Rosemont Hospital, Montreal, QC, CAN
6Hôpital Maisonneuve-Rosemont, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
7Maisonneuve-Rosemont Hospital, Montreal, Qc, CAN
8Fred Hutchinson Cancer Center, Seattle, WA
9Hôpital Maisonneuve-Rosemont, Université de Montréal, Institut Universitaire d'Hémato-Oncologie et de Thérapie cellulaire, Montreal, QC, Canada

5:00 PM

Biqi Zhou, M.D.1,2*, Jia Chen, M.D.1,2*, Tianhui Liu, PhD1,2*, Yanming Zhang, M.D.3*, Yishan Ye, MD4*, Yiyang Ding, M.D.1*, Mingqing Zhu1*, Xiao Ma, M.D.1,5*, Xiaoli Li, M.D.5*, Zhihong Lin, M.D.6*, He Huang, M.D.4*, Yang Xu, M.D.1,2* and Depei Wu, M.D.1,2

1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
2Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
3Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'An, China
4Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Soochow Hopes Hematology Hospital, Suzhou, China
6Hygeia Suzhou Yongding Hospital, Department of Affiliated Renji Hospital of Shanghai Jiao Tong University of Medicine, Suzhou, China

5:15 PM

Reem Alasbali, MD, MBBS1*, Mohsen Alzahrani, MD2*, Saud Alhayli, MD3*, Walid Rasheed, MD3*, Phavina Akhom4*, Karina Wilkerson, MSN, NP5*, Mohammed Essa6*, Riad Elfakih, MD3*, Bader Alahmari, MD2*, Hadeel Samarkandi, PharmD7*, Syed Osman Ahmed, MD3*, Ayman Saad, MD3, Hazza A. Alzahrani, MD3*, Fahad Almohareb, MD3, Mahmoud Aljurf, MD3*, Adetola A. Kassim, MBBS, MS8,9 and Ali D Alahmari, MD3*

1Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Riyadh, Saudi Arabia
2Divison of Hematology & HSCT, Departement of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
3Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
4Vanderbilt hospital, Vanderbilt
5Vanderbilt hospital, Nashville, TN
6King Abdullah Specialist Children’s Hospital, Ministry of National Guard, Riyadh, Saudi Arabia
7King Faisal specialist hospital and research center, Riyadh, Saudi Arabia
8Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
9Vanderbilt-Meharry Sickle Cell Center for Excellence, Vanderbilt University School of Medicine, Nashville, TN

5:30 PM

Simona Piemontese1*, Myriam Labopin2*, Goda Choi, MD3*, Annoek E.C. Broers4*, Ellen Meijer5, Gwendolyn Van Gorkom6*, Montserrat Rovira, MD, PhD7*, Maria Jesús Pascual8*, Simona Sica9*, Jan Vydra10*, Aleksander Kulagin11*, Alexandros Spyridonidis12*, Arnon Nagler13*, Ali Bazarbachi, MD, PhD14, Bipin N. Savani, MD15, Eolia Brissot16*, Jaime Sanz17*, Mohamad Mohty, MD, PhD16 and Fabio Ciceri18,19*

1Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milano, Milano, Italy
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3University of Groningen, University Medical Center Groningen (UMCG), Groningen, Netherlands
4Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
5Department of Hematology, VU Medical Center, Amsterdam, Netherlands
6University Hospital Maastricht, Maastricht, Netherlands
7Hospital Clínic de Barcelona, Barcelona, Spain
8Hematology, Hospital Regional de Málaga, Malaga, Spain
9Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
10Institute of Hematology and Blood Transfusion, Prague, Czech Republic
11b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
12Department of Internal Medicine, Bone Marrow Transplantation Unit, University Hospital of Patras, Patras, Greece
13Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
14American University of Beirut Dept. of Medicine, Beirut, Lebanon
15Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
16Hôpital Saint-Antoine, Sorbonne University, INSERM UMRs 938, Paris, France
17Hematology Department, Hospital Universitari i Politècnic La Fe, VALENCIA, ESP
18Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milano, Italy
19Vita-Salute San Raffaele University, Milan, Italy

5:45 PM

Amado J Karduss, MD1,2, Guillermo Herrera, MD3*, Angela Maria Trujillo, MD4*, Angelica M Cardona5*, Marcos Arango, MD6*, Giovanny Ruiz, MD3* and Rosendo Perez, MD7*

1Bone Marrow Transplantation Program, Instituto de Cancerologia las Americas, Medellin, Colombia
2Hematology Program, University of Antioquia, Medellin, Colombia
3Bone Marrow Transplantation Program, Instituto de Cancerologia las Americas AUNA, Medellin, Colombia
4Instituto De Cancerología Las Américas, Medellín, Antioquia, COL
5AUNA IDEAS, Instituto de Cancerologia las Americas AUNA, Medellin, Colombia
6Bone Marrow Transplant Program, Instituto de Cancerologia las Americas AUNA, Medellin, Colombia
7Instituto de Cancerologia las Americas, Medellin, Colombia

*signifies non-member of ASH